E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- University of Iowa
- Study ID
- NCT07032350
- Status
- Recruiting
Conditions
- Care Giving Burden
- Chronic Pain
- Dementia
- Pain Management
- Palliative Care
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- Web-based pain management support tool — OTHERThe Pain Control Enhancement App (PACE-app) is a web-based tool designed to help family caregivers manage pain in persons with dementia. The app provides a brief screening to identify caregiver challenges and delivers tailored strategies, communication prompts for providers, and an educational resource library. It includes a digital pain diary for tracking daily pain, treatments, and urgent care use, with weekly reports that can be shared with healthcare providers. The app is accessible on any internet-connected device and designed for caregivers with varying levels of digital literacy.
- Usual Pain Management Care — BEHAVIORALCaregivers receive no new intervention; they manage their care recipient's pain according to standard practices. No access to the PACE-app is given during the study period.
Study Details
The goal of this clinical trial is to test whether a web-based application called the Pain Control Enhancement App (PACE-app) can support family caregivers in managing pain for their care recipients with dementia. The main questions it aims to answer are: Is it feasible and acceptable for family caregivers to use the PACE-app? Does using the PACE-app improve caregiver self-efficacy in pain management, adherence to pain treatments, communication with care providers, well-being, and their care recipient's pain conditions? Researchers will compare caregivers who use the PACE-app to those who continue with their usual care practices to see if the app leads to better outcomes for both caregivers and care recipients. Participants will: Be randomly assigned to either the PACE-app group or a usual-care control group Complete online surveys at baseline, 1 month, and 2 months If assigned to the PACE-app group: Use the PACE-app for 1 month to receive tailored pain management strategies and tools, and record their care recipient's pain in a digital diary Participate in an interview about their experience with the app All participation activities can be done remotely or in person.
Key Dates
- Start date
- May 22, 2025
- Status verified
- Jun 2025
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Usual Care GroupCare recipients will continue receiving their regular pain care. Caregivers will complete outcome assessments only. Introductory Meeting (Baseline): Caregivers will attend a 1.5-hour meeting to complete informed consent and baseline REDCap surveys. Follow-up (Month 1 and Month 2): At 1-month and 2-month follow-ups, caregivers will independently complete REDCap surveys (\~45 minutes per follow-up).
- Experimental: App Use GroupCare recipients will continue receiving their regular pain care. Caregivers will use the PACE-app and complete outcome assessments. Introductory Meeting (Baseline): Caregivers will attend a 1.5-hour meeting to complete informed consent and baseline REDCap surveys. Intervention Period (Month 1): Caregivers will use the PACE-app for 1 month, complete a daily pain diary (5-10 minutes/day), and access weekly summary reports to share with providers. Post-Intervention (Month 1): Caregivers will complete REDCap surveys and participate in a 1.5-hour interview on their experience with the app (audio-recorded unless declined). Follow-up (Month 2): Caregivers will complete the same REDCap questionnaires to assess longer-term outcomes.
Primary Outcome Measure
Caregiver Self-Efficacy in Pain Management [ Time Frame: Change from baseline to 1 month and 2 months ]
Central Contacts
- Nai-Ching Chi, PhD, MS, BSN319-335-7064
- Gabriel M Vald, MS, BA515-897-8517
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| College of Nursing | Iowa City | Iowa | 52246 | Nai-Ching Chi, PhD, MS, MSN, BSN (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Iowa City, IA
Related Studies
- Ferritin and Iron Burden in SAH sIRBPHASE1/PHASE2 · Recruiting · Duke University · Iowa City, Iowa
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- Alzheimer's Disease Neuroimaging Initiative 4Enrolling By Invitation · University of Southern California · Birmingham, Alabama
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).PHASE3 · Not Yet Recruiting · Eli Lilly and Company · Phoenix, Arizona